CPHI Milan 2
CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
Small Changes to Tablet Shape Bring Big Results
Editorial Archive

Small Changes to Tablet Shape Bring Big Results

Tablet shape is generally given the most consideration as new products are branded by marketing departments, whereas whole campaigns have been built around a tablet’...
Continue Reading →
When Two is Better than One: The Benefits of Two-Floor Production Facilities for Future-Proof Manufacturing Capability
Editorial Archive

When Two is Better than One: The Benefits of Two-Floor Production Facilities for Future-Proof Manufacturing Capability

The impact of batch transfer methods on the ‘Lean success’ of a plant is starting to be recognised earlier in the plant design process. Before deciding on building a...
Continue Reading →
Tailor-made Product Attributes
Editorial Archive

Tailor-made Product Attributes

Mark Riemer of SternMaid GmbH & Co.KG explores fluid-bed technology, a formative drying process enabling a specific influence on the physical properties of solid...
Continue Reading →
Accelerating the Development of Generic Pharmaceuticals: Developing an Analytical Toolkit Suitable for De-Formulating Complex Reference Products
Editorial Archive

Accelerating the Development of Generic Pharmaceuticals: Developing an Analytical Toolkit Suitable for De-Formulating Complex Reference Products

In its report “Critical Path Opportunities for Generic Drugs”, the FDA emphasises the need for advances in the field of analytical sciences in order to accelerate th...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026